Nektar Therapeutics Securities Fraud Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Nektar Therapeutics · Nektar Therapeutics securities · Ongoing Litigation
Last updated
Case overview
- Defendant company
- Nektar Therapeutics
- Product or service
- Nektar Therapeutics securities
- Court case number
- 5:2026cv01951
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead Plaintiff Application
Participation information
Availability is based on each listed participation option and its deadline.
Lead Plaintiff Application
Purchasers of Nektar Therapeutics securities between February 26, 2025 and December 15, 2025, inclusive.
Investors seeking to serve as lead plaintiff were required to move the court by May 5, 2026.
- Type
- Lead Plaintiff
- Status
- Deadline passed
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Nektar Therapeutics Securities Fraud Class Action
Barchart.com ·
- Nektar Therapeutics Securities Fraud Class Action
Barchart.com ·